Business
Ondine technology used in major Canadian hospital
Ondine technology used in major Canadian hospital.
About this update from Ondine Biomedical, Inc.
[{"type":"text","content":"\n\n7 August 2023\nONDINE BIOMEDICAL INC.\n \n(\"Ondine Biomedical\", \"Ondine\" or the \"Company\")\n \nOndine technology used in major Canadian hospital\nKelowna General Hospital is using Ondine's photodisinfection technology to reduce hospital-acquired infections (HAIs) in patients undergoing orthopedic surgery\n· One in every 190 Canadians will get an HAI in their lifetime, with a 4% fatality rate.[i]\n· Antimicrobial resistance (AMR) has been reported as high as 81% in Canada.[ii]\n· One in 19 deaths in Canada are attributable to antibiotic-resistant bacterial infections.\nCanadian life sciences company Ondine Biomedical (LON: OBI) has partnered with Kelowna General Hospital (KGH) on a pilot program to prevent hospital-acquired infections (HAIs). During the pilot, all orthopedic patients at KGH will be treated with Ondine's Steriwave® nasal photodisinfection therapy prior to surgery.\nOndine's revolutionary Steriwave photodisinfection treatment kills all types of pathogens - viruses, bacteria, and fungi - without causing resistance and is already in use at a number of hospitals across Canada, including Vancouver General Hospital (VGH) and The Ottawa Hospital. In these hospital settings, pre-surgical use of Steriwave has resulted in significant improvement in post-surgical outcomes including lower rates of infection, reduced patient length of stay, fewer readmissions, and lower rates of antibiotic prescribing.[iii],[iv],[v] Recent research conducted at VGH found the SSI mortality rate was cut by 59% among patients who received Steriwave nasal photodisinfection before surgery compared to those who did not.[vi] \nHAIs are a serious problem in hospitals across Canada, with one in every 195 Canadians now expected to contract an HAI in their lifetime.[vii] HAIs are also becoming harder to treat due to rising rates of antimicrobial resistance (AMR) which are making commonly used antibiotics increasingly ineffective. Resistance rates for mupirocin, an antibiotic commonly used to prevent HAIs, have been reported as high as 81%.[viii] It is estimated that 1 in 19 deaths in Canada are now attributable to antibiotic-resistant infections.[ix]\nHAIs also place additional strain on the healthcare system, as patients with an HAI can spend 30 days longer in hospital, signi...